KRT8 and carcinoma: Quantification of GPx2 KD tumours and paired lung mets confirmed a higher percentage of carcinoma cells co-expressing p63 with KRT8/KRT14 than with KRT8 or KRT4 at both sites (Fig. 6f, g).